Regulatory Affairs | Regulatory Compliance | Scientific Affairs
During the last 10 years, a total of 1,345 mergers and acquisitions of pharmaceutical assets and pharmaceutical companies were concluded. According to DealSearchOnline.com disclosed numbers, these deals totaling more than $694 billion.
Innovation and rapid change creates a very complex environment in which a drug developer must operate. A pharmaceutical manufacturer must keep up with rapid change, control financial risk, and meet the requirements of regulatory bodies. In order to succeed in this complex new environment, many drug developers and manufacturers are aligning themselves with others for additional competencies, or are looking to partner with a competitor.
We can help in advancing your core competencies and find alliances that provide higher return on investment. We help in forming partnerships with organizations that possess the necessary expertise in pilot scale drug development, scale up and validation of the manufacturing process or manufacturing for the mass market. We ensure successful partnership by facilitating good communication and creating mutual respect for the skills and experience each party brings to the table.
We can complement your development and commercialization skills with our expertise in the following areas:
- Assist in seeking and setting up partnership
- Search and Acquisition of Companies
- Assist in acquisition of Products
- Due Diligence Audits
- Preparation and assessment of Commercial Agreements
- Preparation and or assessment of Quality Agreements